Literature DB >> 15494537

Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells.

Gabriela Riemekasten1, Dirk Langnickel, Philipp Enghard, Reinmar Undeutsch, Jens Humrich, Fanny M Ebling, Berthold Hocher, Tiina Humaljoki, Hans Neumayer, Gerd-R Burmester, Bevra H Hahn, Andreas Radbruch, Falk Hiepe.   

Abstract

T cells that recognize nucleoproteins are required for the production of anti-dsDNA Abs involved in lupus development. SmD1 83-119 (a D1 protein of the Smith (Sm) proteins, part of small nuclear ribonucleoprotein) was recently shown to provide T cell help to anti-dsDNA Abs in the NZB/NZW model of lupus. Using this model in the present study, we showed that high dose tolerance to SmD1 (600-1000 microg i.v. of SmD1(83-119) peptide/mo) delays the production of autoantibodies, postpones the onset of lupus nephritis as confirmed by histology, and prolongs survival. Tolerance to SmD1 83-119 was adoptively transferred by CD90+ T cells, which also reduce T cell help for autoreactive B cells in vitro. One week after SmD1 83-119 tolerance induction in prenephritic mice, we detected cytokine changes in cultures of CD90+ T and B220+ B cells with decreased IFN-gamma and IL-4 expression and an increase in TGFbeta. Increased frequencies of regulatory IFN-gamma+ and IL10+ CD4+ T cells were later detected. Such regulatory IL-10+/IFN-gamma+ type 1 regulatory T cells prevented autoantibody generation and anti-CD3-induced proliferation of naive T cells. In conclusion, these results indicate that SmD1 83-119 peptide may play a dominant role in the activation of helper and regulatory T cells that influence autoantibody generation and murine lupus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494537     DOI: 10.4049/jimmunol.173.9.5835

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cells.

Authors:  Bharati Matta; Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

Review 2.  Genes, tolerance and systemic autoimmunity.

Authors:  Ram P Singh; Richard T Waldron; Bevra H Hahn
Journal:  Autoimmun Rev       Date:  2011-11-30       Impact factor: 9.754

Review 3.  The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.

Authors:  Nicole H Kattah; Michael G Kattah; Paul J Utz
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 4.  CD8+ T regulatory cells in lupus.

Authors:  Ram P Singh; David S Bischoff; Bevra H Hahn
Journal:  Rheumatol Immunol Res       Date:  2021-12-15

5.  Temporal profiling of the adipocyte proteome during differentiation using a five-plex SILAC based strategy.

Authors:  Henrik Molina; Yi Yang; Travis Ruch; Jae-Woo Kim; Peter Mortensen; Tamara Otto; Anuradha Nalli; Qi-Qun Tang; M Daniel Lane; Raghothama Chaerkady; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2009-01       Impact factor: 4.466

Review 6.  Regulatory T cells in systemic lupus erythematosus: past, present and future.

Authors:  David A Horwitz
Journal:  Arthritis Res Ther       Date:  2008-11-14       Impact factor: 5.156

7.  The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.

Authors:  Beatriz Teresita Martín-Márquez; Minoru Satoh; Rogelio Hernández-Pando; Erika Aurora Martínez-García; Marcelo Heron Petri; Flavio Sandoval-García; Oscar Pizano-Martinez; Trinidad García-Iglesias; Fernanda Isadora Corona-Meraz; Monica Vázquez-Del Mercado
Journal:  PLoS One       Date:  2021-10-27       Impact factor: 3.240

8.  Novel targets for immunotherapy in glomerulonephritis.

Authors:  Mary H Foster
Journal:  Biologics       Date:  2008-09

9.  CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice.

Authors:  Olivia Weigert; Caroline von Spee; Reinmar Undeutsch; Lutz Kloke; Jens Y Humrich; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2013-02-27       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.